ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • A Case of Graft-versus-Host Disease Following Pancreas-Kidney Transplant

    P. Shelat1, C. Alquist2

  • A Case-Match Cohort Comparison of the Safety and Efficacy of Basiliximab for Immunosuppression Holiday in Lung Transplant Patients

    M. M. Eiting1, J. E. Clark1, T. L. Astor2, J. Palafox2, C. Rogers Marks1, G. Waldman1

  • A Comparative Analysis of Kidney Allograft Outcomes in Steroid Use versus Steroid Discontinuation After Basiliximab Induction: Unos Data Base Study

    F. Cardarelli, H. Patel, A. Aala

  • A Comparison Between Combined Liver Kidney Transplants to Liver Transplants Alone: A Systematic Review and Meta-analysis

    S. Bouari1, E. A. Rijkse1, H. J. Metselaar2, M. W. van den Hoogen3, J. N. Ijzermans1, J. de Jonge1, W. G. Polak1, R. C. Minnee1

  • A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression

    E. Huang, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan

  • A Comparison of Pediatric Intestine Transplant Between the Current Era (2015-2019) and the Peak Period (2002-2006)

    S. Horslen1, T. Weaver2, M. Skeans2

  • A Comparison of Plasmapheresis Methods in the Treatment of Late Antibody Mediated Rejection

    Y. Caliskan1, H. Yazici2, A. B. Dirim2, E. Aksoy2, S. Safak2, N. Garayeva2, S. Mirioglu2, O. Yegit2, O. A. Oto2, Y. Ozluk3, S. Besisik4, A. Turkmen2, K. Lentine1

  • A Cost Benefit Analysis of Different Minimal Access Donor Nephrectomy Techniques Performed at a Busy Transplant Centre

    H. Sharma1, A. Odougoudar2, A. Sharma2, D. Ridgway2, A. Hammad2, S. Mehra2

  • A Delphi Panel to Develop Public Educational Materials About Vascular Composite Allotransplantation (VCA)

    C. Sidoti1, A. Ferzola2, H. Sung2, S. Rasmussen2, E. Gordon3, N. Anderson3, J. Uriarte3, C. Cooney4, G. Brandacher4, M. Levan2

  • A Dynamic Markov Model to Assess the Cost-Effectiveness of the Kidney Team at Home Intervention in the Netherlands

    S. Redeker1, S. Ismail1, H. van Eeren1, E. K. Massey2, W. Weimar2, M. Oppe3, J. van Busschbach1

  • A Fresh Look at Urbanicity and Its Impact on Additions to the Kidney and Liver Transplant Wait Lists

    W. R. Johnson, S. A. Rega, I. D. Feurer, S. J. Karp

  • A Kidney Waitlist Outcomes Timeline to Visualize Candidate Offers and Outcomes

    C. Schaffhausen1, J. Miller2, A. Matas3, A. Israni4, A. Wey5, A. Hart4

  • A Machine Learning-Based Predictive Model for Outcome of Covid-19 in Kidney Transplant Recipients

    I. Revuelta1, F. Santos-Arteaga2, D. Di Caprio3, E. Montagud-Marrahi1, F. Cofan1, J. Torregrosa1, M. Bodro4, A. Moreno4, P. Ventura-Aguiar1, D. Cucchiari1, N. Esforzado1, G. Piñeiro1, J. Ugalde-Altamirano1, J. Campistol1, A. Alcaraz5, B. Bayès1, E. Poch1, F. Oppenheimer1, F. Diekmann1

  • A Mechanistic Evaluation to Guide the Optimal Immunosuppression Adjustment Strategy in Transplant Patients with COVID-19

    V. Hall, V. Ferreira, D. Kumar, A. Humar

  • A Meta-Analysis of Endoscopic Stents in the Treatment of Anastomotic Biliary Strictures After Liver Transplantation

    F. Zhou1, M. Mieth1, C. Rupp2, A. Mehrabi1, A. Nickkholgh1

  • A Molecular Classifier Identifies Antibody-Mediated Rejection-Associated Changes in Lung Transplant Biopsies

    K. S. Madill-Thomsen1, K. M. Halloran2, M. Parkes1, P. F. Halloran1, &. the INTERLUNG Study Group3

  • A Multi-institutional Study of Renal Outcomes in Uterus Transplantation

    D. Sawinski1, L. Johannesson2, J. Kristen3, J. Fronek3, P. Porrett4

  • A Multimodal Interrogation of Human Renal Allografts

    D. Dadhania1, R. Ding1, H. Xu2, C. Lee1, C. Snopkowski1, T. Salinas1, T. Muthukumar1, J. Lee1, R. Woodward2, M. Grskovic2, S. Dholakia2, M. Suthanthiran1

  • A New Triage-based Approach to Managing Transplant Referrals

    H. L. Walther

  • A Noninvasive Diagnostic Approach for Molecular Monitoring of Face Transplant Recipients

    C. Snopkowski1, P. Rabbani2, H. Yang1, Z. Berman2, G. Diep2, C. Li1, T. Muthukumar1, R. Ding1, D. Ceradini2, M. Suthanthiran1

  • A Novel Liver Assist Device as a Bridge to Liver Transplantation in Acute on Chronic Liver Failure Patients with Multi-Organ Failure

    S. Ahmad1, I. W. Liou1, J. Reyes2, R. Bakthavatsalam3, N. C. Smith4, R. L. Carithers1, C. Martin1, D. Gao5

  • A Novel Mouse Model of Cardiac Allograft Vasculopathy

    H. Tsuda1, E. Reed2, W. Baldwin1, R. Fairchild1

  • A Patient-Centered Perspective on Progress in Transplantation

    B. Hickner1, N. Galvan2, R. Cotton2, C. O'Mahony2, J. Goss2, A. Rana2

  • A Payer’s Perspective: The Cost of Hemodialysis versus Living Donor Kidney Transplant for Kidney Failure Patients in Nigeria

    J. Lang1, I. James2, D. Da Rocha Afodu1, C. G. Okwuonu3, O. Ekwenna1

  • A Pediatric Liver Allograft with an Occult Urea Cycle Defect Carrier Mutation Causing Delayed Graft Function and Metabolic Crisis After Liver Transplantation

    A. Peters, M. Rezvani, C. Prada, K. Campbell

  • A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of At-1501

    S. Perrin1, A. Gill2, C. Gill2, P. Gustafson1

  • A Psychosocial Clinician Rating Scale is Used Differently Across Solid Organ Teams within a Single Transplant Center

    S. Entenman1, T. Chaffee2, M. Pienta3, B. Young3, E. Clifton1, J. Mellinger4, L. McElroy5, G. Winder1

  • A Question with Multiple Answers: Do Renal Transplant Recipients Require Steroid Maintenance Following Thymoglobulin Induction?

    A. Aala, H. Patel, F. Cardarelli

  • A Randomized, Multicenter, Blinded Study Assessing the Effects of Gaseous Nitric Oxide in an Ex Vivo System of Human Lungs

    M. G. Hartwig1, J. A. Klapper1, N. Poola2, A. Banga3, P. G. Sanchez4, J. S. Murala3, J. L. Potenziano2

  • A Reliable Non Invasive Alternative to Surveillance Renal Allograft Biopsy

    R. Jain, S. Thaduri, V. Kumar, C. Kew, B. Julian, G. Towns, S. Ong, F. Ahmed, S. Mehta, G. Agarwal

  • A Retrospective Analysis of the Safety and Efficacy of Apixaban After Lung Transplant

    T. Sam1, K. Reininger2, R. Patel1, C. Naik1, K. Ausloos1, R. Rosenblatt1, T. Grazia1, I. Lam3

  • A Shift in Paradigm: Phosphatidylethanol Testing to Monitor for and Address Alcohol Recidivism Following Liver Transplantation

    F. M. Nimri1, S. Naffouj1, F. Askar1, A. Singh2, H. Gonzalez2, S. Jafri2

  • A Significantly Shorter Waiting Time to Subsequent Kidney Transplant After Liver Transplant by Using Safety Net Policy

    P. Homkrailas, S. Bunnapradist

  • A Single Nucleotide Polymorphism within the FCGR3A 158 F/V Gene is Associated with Decreased Survival of Renal Allografts with Chronic Active Antibody-Mediated Rejection

    N. H. Litjens, A. M. Peeters, J. A. Kal-van Gestel, M. Klepper, M. G. Betjes

  • A Small Molecule Inhibitor of Toll-like Receptor-4 TAK-242 Attenuates IBMIR Against Human Islets

    J. Mattke1, S. Vasu1, K. Kumano1, Y. Liu1, C. M. Darden1, M. C. Lawrence1, R. R. Kane2, B. Naziruddin1

  • A2 to B Deceased Donor Renal Transplantation Outcome Analysis: Single Center Experience

    S. Bindroo, M. Doshi

  • Accelerated Bronchiolitis Obliterans After Lung Transplant Promoted by an ATG16L1 Mutation is Coupled to Mitochondrial Damage and Metabolic Alterations in Monocyte-derived Antigen Presenting Cells

    M. Cano1, D. Zhou1, D. Kreisel1, C. Chen2, K. Pugh1, D. Byers1, R. Hachem1, A. Gelman1

  • Accounting for Survivor Bias in Transplant Benefit Models

    E. M. Schnellinger1, E. Cantu2, M. O. Harhay1, D. E. Schaubel1, S. E. Kimmel1, A. J. Stephens-Shields1

  • Achilles Heel No Longer: Marked Decline in Early Relaparotomy and Allograft Pancreatectomy Rates Following Simultaneous Kidney-Pancreas Transplantation in the Contemporary Era

    B. Sharda1, K. Gurung2, R. Stratta2, A. Farney2, G. Orlando2, C. Jay2, A. Reeves-Daniel3, A. Mena-Gutierrez3, N. Sakhovskaya3, W. Doares4, S. Kaczmorski4, M. Magid4, J. Rogers2

  • Acoustofluidic Device to Remove Donor Specific Antibody in a Sensitized Animal Model

    J. Kwun1, E. David2, Y. Gu3, Z. Ma3, M. Kuchibhatla4, G. Arepally5, T. J. Huang3, E. T. Chambers2

  • Acute Dialysis, Mortality and Renal Failure After Heart Alone Transplant by Egfr and Dialysis Requirement in the United States

    M. Aljuhani1, T. Alexy1, S. Jackson2, C. Martin1, R. Kandaswamy3, S. Riad1

  • Acute Kidney Injury After Lung Transplantation: Incidence, Risk Factors and Outcomes. Results from a Monocentric Retrospective Cohort Study

    M. Gandolfo1, C. Bellincioni1, L. Morlacchi2, V. Rossetti2, F. Blasi2, P. Messa1

  • Acute Kidney Injury Requiring Dialysis in Heart Transplant Recipients is a Risk Factor for Graft Failure and Overall Mortality

    M. A. Merzkani, H. Murad, A. Pottebaum, A. Java, A. Malone, J. Schilling, A. Itoh, R. Delos Santos, T. Alhamad

  • Additional Value to Participation in a National Paired Kidney Exchange Program: Exploring Characteristics of Chain End Living Donors and Waitlist Recipients

    N. Osbun1, A. Thomas2, M. Cooper3, S. Flechner4, D. Segev2, J. Veale1

  • Addressing a Need in Transplant Clinical Care: Creation of the Organ Transplant Caregiver Toolkit

    H. Bruschwein1, G. Chen2, A. Ortega3, W. Balliet4, T. Coco5, C. Thomas6, B. Hansen5, D. Richardson7, K. Canavan8, C. Burch9, A. Yaldo10, M. Jesse11

  • Adenovirus-Specific T Cells for Steering of Immunosuppression After Pediatric Kidney Transplantation in the Randomized Controlled Ivist Trial

    T. Ahlenstiel-Grunow1, X. Liu2, R. Schild3, J. Oh3, C. Taylan4, L. T. Weber4, H. Staude5, M. Verboom6, C. Schröder7, R. Sabau7, A. Großhennig2, L. Pape1

  • Adjuvant Immunotherapy for Liver Transplant Recipients with Hepatocellular Carcinoma Using Donor Liver-derived Natural Killer Cells

    M. Ohira1, R. Hotta1, Y. Imaoka1, K. Sato1, N. Tanimine1, Y. Tanaka1, S. Nishida2, A. Tzakis2, H. Ohdan1

  • Adjuvant Treatment Shapes the Bone Marrow Myeloid Compartment Towards an Immunosuppressive Phenotype That Can Suppress Allograft Rejection

    J. Ge1, E. Anderson1, J. F. Markmann2, A. Cuenca1

  • Admission to the Intensive Care Unit Post-liver Transplantation: One Academic Center’s Experience

    C. D. Santos, A. Grek, T. Krider

  • Adult Combined Liver-Heart Transplantation: The United States Experience

    I. A. Ziogas1, S. P. Alexopoulos1, W. K. Wu1, L. K. Matsuoka1, M. A. Rauf1, M. Izzy2, R. Perri2, K. H. Schlendorf3, J. N. Menachem3, A. S. Shah4

  • Adult Deceased Donor Liver Transplantation with Split Liver Grafts vs Whole Liver Grafts. A Single-Center Experience

    P. Vargas1, C. Argo2, H. Zachary2, M. Stotts2, N. Intagliata2, P. Northup2, S. Pelletier1, J. Oberholzer1, N. Goldaracena1

  • Adults Undergoing First Time Liver Transplantation with Biliary Atresia: An Analysis of the United Network for Organ Sharing Database

    E. Hsu1, J. Perkins2, S. P. Horslen1, A. A. Dick1, N. M. Blondet1, J. D. Reyes2

  • Age and Racial Disparities in Access to Re-kidney Transplantation

    S. S. Patole1, J. Ahn1, S. Sandal2, D. Segev1, M. McAdams Demarco3

  • Albumin Level Prior to Liver-Directed Therapy is a Risk Factor of Waitlist Tumor Progression Independent of HCC Burden

    P. Thevenot, K. Nunez, T. Sandow, M. Hibino, P. Wright, J. Patel, D. Fort, A. Cohen

  • Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients

    K. Walter, L. Mincemoyer, J. Giang, J. Suero, N. Shah, K. Szempruch

  • Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis

    S. Panchal1, D. Kaplan2, D. Goldberg3, N. Mahmud2

  • Aligning Pediatric Waiting List and Post-Transplant Outcomes with the Adult Lung Allocation Score

    M. Skeans1, A. Wey1, E. Lease2, C. Lehr3, J. Alcorn4, R. Goff4, D. Stewart4, M. Valapour3

  • Allocating Kidneys in Optimized Circles: Logistics are More Important Than Distance

    R. Saidi, R. Shahbazov, M. Hanlon, M. laftavi

  • Allocation Changes and Covid Effect on Waiting Time for Liver Transplantation

    L. Dageforde1, Q. Yuan2, N. Elias1

  • Allograft Discard Risk Index for Heart Transplantation

    R. M. Reul1, A. A. Saleem1, C. N. Keller1, T. H. Malik1, J. A. Goss2, A. A. Rana2

  • Allograft Discard Risk Index for Lung Transplantation

    R. M. Reul, G. Loor, P. S. Garcha, A. A. Rana

  • Allograft Function and Baseline Donor Derived Cell Free DNA in Kidney Transplant Recipients: One Size Doesn’t Fit All

    K. K. Sureshkumar, A. Grazier, B. Chopra

  • AlloMap Kidney Gene Expression Profiling Discriminates Rejection from Immuno-Quiescence in Renal Transplant Recipients

    E. Akalin1, A. Djamali2, H. Xu3, X. Jin3, R. N. Woodward3, S. Dholakia3, J. S. Bromberg4

  • Alloreactive Memory T Follicular Helper Cells Rapidly Differentiate Into Effectors Independent of B Cell Memory Following Retransplantation

    S. Zeng, E. S. Crichton, I. R. Badell

  • Alpha 1-antitrypsin Reduces Cytokine Elaboration in a Xenogeneic Lung Transplantation Model

    L. Burdorf1, C. Laird2, T. Zhang2, M. R. Connolly1, Z. Habibabady1, S. Pratts1, S. Miura1, F. Pollok1, W. Eyestone3, C. J. Phelps3, D. L. Ayares3, A. M. Azimzadeh1, R. N. Pierson III1

  • Alterations in Mineral Metabolism of Living Kidney Donors: Prospective Observational Study

    H. Lee1, E. Ko1, H. Cho2, C. Yang1, B. Chung1

  • AM PAC Scores and Liver Transplant Resource Utilization

    M. Pierpont1, M. Gosselin2, K. Robichaux3, A. Kumar1, J. Buggs4, N. Kemmer5

  • Ambient Air Pollution and Changes in Cognitive Function Among Kidney Transplant Recipients

    Y. Feng1, M. Jones2, N. Chu2, D. Segev1, M. McAdams Demarco1

  • Among Patients with Pre-Transplant Donor-Specific Antibodies, the Disappearance of the Donor-Specific Antibodies at 3 Months is Not Associated with Less Rejection

    S. Parajuli, A. Djamali, A. Kharel, B. Alzoubi, N. Bath, N. Garg, F. Aziz, D. Mandelbrot

  • An Early Look at the OPTN Kidney Paired Donation Pilot Program’s New Priority Points Policy

    S. E. Booker1, R. Leishman1, D. E. Stewart1, T. Sandholm2, J. Dickerson3, M. Pavlakis4, V. Casingal5

  • An Evaluation of Pjp Prophylaxis and Anemia Among Renal Transplant Recipients

    J. Hedvat, N. Poladi, D. Salerno, G. Dube, N. Lange

  • An HLA Class II Matching Strategy That Predicts De Novo Donor-specific HLA Antibody Formation Using Low Resolution HLA Types

    L. Hidalgo1, I. Martinez Juarez2, L. Morales Buenrostro2, S. Shojai3, P. Campbell1

  • An Immune-modulatory Strategy to Mitigate Hepatic Ischemia/reperfusion Injury in a Murine Model

    A. Kobayashi, A. Wanchoo, S. Farhadi, J. Simonovich, S. Duarte, V. Boominathan, S. Shrestha, G. Hudalla, B. G. Keselowsky, A. Zarrinpar

  • An Investigation of Surgeon’s Effect on Deceased-Donor Kidney Offers and Transplant Outcomes

    A. C. Randa, J. P. Roberts

  • An Unexpected Case of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Overlooked Pretransplant, but Then Diagnosed Early After Kidney Transplant with a Negative Patient Outcome: A Case Report

    W. Hoffman, M. Waybill, H. Yang, D. Ladie, M. Singh

  • An Unusual Viral Tropism in a Solid Organ Transplant Recipient

    P. Singh, A. Bentall, C. Langstraat, A. Swanson, P. Deziel, Y. Huang, R. Razonable

  • Analysis of Single Cell RNA Sequencing Data to Define Biomarkers of Human Liver Immune Tolerance

    B. Rocque1, A. Barbetta1, P. Singh1, C. Goldbeck1, D. G. Helou2, E. Loh3, N. Ung4, J. S. Lee4, O. Akbari2, J. Emamaullee1

  • Analysis of the Difference of the Monitoring Results of Tcr High Variable Area in Renal Transplant Recipients After Treatment with Different Immune Induction Schemes

    P. Tian, F. Han, M. Dou, B. Zheng, G. Deng, X. Ding, W. Xue

  • Analyzing the Impact of Covid-19 in the Hospitalized Cohort of Liver Transplant Recipients: An Early Systematic Review and Meta-Analysis

    J. Kumar1, I. Reccia2, P. Bachul1, D. DiSabato,1, R. Barth1, J. Fung1, T. Baker1, P. Witkowski1

  • Angiotensin II Type-1 Receptor Antibodies are Associated with Inferior Renal Allograft Survival

    P. Martin, E. Santos, N. Gunby, M. Willicombe

  • Anonymous Live Liver Donor Perspectives on Anonymity in the Donation Process

    S. S. Humar, N. Selzner, J. Jung, S. Krause, S. Abbey

  • Anterior Rectus Sheath versus Gibson Incision for Kidney Transplantation – University of Chicago Experience

    G. S. Generette, P. J. Bachul, P. E. Borek, K. Jayant, A. Perez-Gutierrez, B. Juengel, Y. T. Becker, R. Barth, J. Fung, P. Witkowski

  • Anterior Rectus Sheath versus Standard Gibson Approach to Kidney Transplantation: A Randomized Double-blinded Controlled Trial

    P. Murthy, M. Lyon, M. Fascelli, M. Spinner, E. Miller, Y. Lin, D. Goldfarb, V. Krishnamurthi, A. Wee, M. Eltemamy

  • Anti-CD272 Antibody (6B2) Generated Foxp3+Regulatory T Cells and Suppressed Donor Specific Antibody in Murine Cardiac Transplant Model

    Y. Yamamoto1, M. Uchiyama2, K. Uchida3, H. Yagita3, M. Niimi1

  • Anti-CD8 Immuno-PET for Non-invasive Tracking of Early Graft Rejection in a Non-human Primate Kidney Transplant Model

    K. Bruestle1, R. Tavare2, F. Fredriksson1, E. Duggan1, F. Huang1, B. Bhola1, J. Giurleo2, R. Foster2, P. Krueger2, M. Dobosz2, D. Ekanayake-Alper1, H. Sakai1, B. Piegari1, J. Castrillion1, S. M. Coley1, O. Harari2, A. Mintz1, D. Ma2, A. Griesemer1

  • Anti-HLA-DP Antibodies Positive – A Retrospective Review of Outcomes in Renal Transplantation- Single Centre Experience

    O. Piscoran1, J. Worthington2, R. Dhillon1, T. Augustine1, M. Picton1, M. Morton1, S. Bhutani1

  • Anti-pig IgE and IgA Antibodies in Sera of (i) Naïve Primates and (ii) Non-human Primates Sensitized to Pig Xenografts

    H. Hara, Q. Li, H. Iwase, T. Yamamoto, D. Ayares, D. K. Cooper

  • Antibodies to Hla Molecules Lead to Induction and Release of Circulating Exosomes with Lung Self-Antigens

    R. Ravichandran, M. Smith, R. Bremner, T. Mohanakumar

  • Antibody-mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient: A Case Report

    A. Arjuna, M. T. Olson, S. Tokman, R. Walia, T. Mohanakumar, A. S. Hashimi, M. A. Smith, R. M. Bremner, A. Omar

  • Application of Incisional Wound Vac to Decrease Wound Complications and Surgical Site Infections: A Single Center Pilot Project

    E. K. Venniro, M. Dokus, J. Taylor, R. Kashyap

  • Application of Linear Discriminant Analysis (lda) to Differentiate Acute Rejection (ar) and Acute Dysfunction Non-Rejection (adnr) in Liver Transplant Recipients

    M. Miller1, R. Sinha1, J. Weems1, J. Holman2, M. Altrich1, S. Kleiboeker1, J. Levitsky3

  • Are All DSA’s the Same? Are We Ready for Precision Medicine in Pediatric LT?

    S. E. Shin1, M. Lee1, N. Yazigi2, K. Khan2, S. Kaufman2, J. Ahn3, O. Timofeeva4, U. Ekong2

  • Are Liver Transplant Center Websites Accessible to All?

    C. E. Jacobson1, R. Olmeda Barrientos2, M. A. Anderson3, M. J. Englesbe3, S. A. Waits3, V. S. Valbuena3

  • Are Pre-Transplant Diabetics on ACE Inhibitors at Risk for More Renal Dysfunction After Heart Transplantation?

    M. Kittleson, J. Patel, D. Chang, N. Patel, S. Kim, T. Singer-Englar, R. Skorka, A. Hage, L. Czer, F. Esmailian, J. A. Kobashigawa

  • Are Tacrolimus Concentrations Reduced with Direct-acting Antiviral Administration in Transplant Recipients?

    K. Huang, K. Farrow, M. Christian

  • Artificial Neural Network Application for MELDNa Prediction

    L. Pruinelli1, M. Nguyen1, S. Olson1, J. Zhou1, J. Schold2, T. Pruett1, S. Ma1, G. Simon1

  • Assessing Liver Transplant Outcomes Utilizing Post-Cross Clamp Offers

    K. Pont1, E. Macdonough1, D. Das2, K. Valenti1, P. Morgan1, B. Aqel1, A. Mathur1, A. Moss1, K. S. Reddy1, C. Jadlowiec1

  • Assessing the Accuracy of the Lung Allocation Score

    N. Dussault1, W. Parker1, R. Jablonski1, E. Garrity1, M. Churpek2

  • Assessing the Impact of Acute Major Adverse Kidney Events on Clinical Outcomes in Heart Transplant Recipients

    J. E. Kelly1, C. Perez1, D. Taber1, R. J. Tedford2, B. McMahon2, S. Alzaidi1, H. B. Meadows1

  • Assessing the Impact of the New Liver Allocation Policy on Transplant Center and Organ Procurement Organization Logistics

    W. P. Sawyer1, A. Gracon2

  • Assessing the Prevalence of Risk Factors for Osteoporosis and Rate of Screening by Dexa Scan in Patients Referred for Liver Transplant Evaluation

    A. France1, J. Kirk2, M. Dokus2, B. Al-Judaibi2, M. Laryea2

  • Assessment of Donor-Derived Cell-Free DNA Performance Characteristics Across the Spectrum of TCMR and ABMR After Kidney Transplant

    L. Bu1, S. Anand2, A. Pai3, J. S. Bromberg4, T. Alhamad5, V. Bowers6, I. Moinuddin7, S. Ghosh8, W. Tian8, E. Stites9, G. Gupta7

  • Association Between Cumulative Antithymocyte Globulin Dosing and Adverse Outcomes in Pediatric Heart Transplant Recipients

    J. Chen1, D. Salerno1, H. Corbo1, S. Shah2, A. Rothkopf3, I. D. Lytrivi3

  • Association Between Donor-Recipient Genetic Matching and Acute Rejection in Kidney Transplantation

    R. Cao1, V. Arthur2, J. Chen2, B. Keating2, C. Dorr3, D. Schladt3, G. Onyeaghala3, R. Mannon4, A. Matas1, R. Remmel1, N. Pankratz1, B. Wu1, W. Oetting1, P. Jacobson1, A. Israni3, W. Guan1

  • Association Between HLA Class II and TLR4 Regulates HLA-II Stimulated P-selectin Expression and Monocyte Capture to Endothelial Cells

    Y. Jin, J. Nevarez-Mejia, E. F. Reed

  • Association of Belatacept Conversion on Patient and Allograft Survival in Kidney Transplant Recipients with Congestive Heart Failure

    H. Mogallapalli

  • Association of Delayed Graft Function with Mortality Post-kidney Transplantation

    N. Eguchi1, H. Ichii2, F. J. Ferrey1, U. G. Reddy1, D. C. Dafoe2, H. Seo3, K. Kalantar-Zadeh1, E. Tantisattamo1

  • Association of Donor Hepatitis C Virus Infection Status and Risk of Bk Polyomavirus Viremia After Kidney Transplantation

    V. S. Potluri1, D. E. Schaubel1, M. E. Sise2, B. P. Concepcion3, R. C. Forbes1, E. A. Blumberg1, D. Goldberg4, P. P. Reese1, R. Bloom1, D. Shaffer3, R. Chung2, D. Sawinski1, I. Strohben2, N. Elias2, A. Azhar5, M. Shah1, J. Eason5, L. A. Binari3, M. Talwar5, V. Balaraman5, A. Bhalla5, B. Besharatian1, M. Z. Molnar5

  • Association of Donor-Derived Cell-Free DNA with Severity of Interstitial Fibrosis and Cortical Atrophy Lesions Following Kidney Transplantation

    L. Bu1, E. Stites2, V. Bowers3, T. Alhamad4, J. S. Bromberg5, G. Gupta6, I. Moinuddin6, S. Ghosh7, W. Tian7, A. Pai8, S. Anand9

  • Association of Immune Cell Markers with Adverse Outcomes in the First 6 Months Post-pediatric Heart Transplantation

    J. Chen1, D. Salerno2, H. Corbo1, S. Shah3, A. Rothkopf4, I. D. Lytrivi4

  • Association of Kidney Function with Patient Reported Outcomes After Kidney Transplantation

    G. S. Kochar, S. A. Rega, I. D. Feurer, A. Dreher, H. Schaefer, D. Shaffer, R. C. Forbes, C. W. Pinson, B. P. Concepcion

  • Association of Obesity and Early Post Kidney Transplantation Complications

    V. Sandra, N. Sanichar, D. Tsapepas, K. L. King, J. Van Bever, K. Toma, A. Hussain, S. Mohan

  • Associations of Lack of Insurance and Other Sociodemographic Traits with Deficiencies in Follow-Up After Living Kidney Donation

    K. Lentine1, R. Hays2, N. Lam3, A. Tietjen4, A. Muiru5, H. Xiao1, A. Garg6, C. Thomas7, G. McNatt7, R. Howey8, U. Lebron-Banks9, M. Cooper10, M. Conboy11, B. Kasiske11

  • Associations of Mammalian Target of Rapamycin Inhibitors with Post-Transplant Malignancies and All-Cause Mortality: Cause-Specific Competing Risks and Composite Outcomes Analyses

    A. H. Santos1, E. Bueno1, M. A. Leghrouz1, W. Xuerong2

  • AT-1501, a Novel and Clinically Applicable CD40L Specific Monoclonal Antibody, Promotes Islet Allograft Survival in Nonhuman Primates

    D. Berman1, N. Kenyon1, M. Willman1, A. Gill2, S. Perrin3, C. Ricordi1

  • Atg16l-Dependent Autophagy Attenuates Procession of Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction via Regulating Tumor Necrosis Factor Alpha (tnf-α) Induced Endmt

    Z. Gui, Z. Wang, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Athena – Effect of Primary Immunosuppression on Development of De Novo Donor Specific Antibodies within First Year After Kidney Transplantation

    W. Arns1, A. Philippe1, V. Ditt1, I. A. Hauser1, F. Thaiss1, C. Sommerer1, B. Suwelack1, A. Finkel2, C. Schiedel2, D. Dragun1, B. Nashan1

  • Attitudes of Obese Kidney Transplant Candidates Towards Bariatric Surgery

    C. LaVerne, V. Thompson, G. Aguiluz, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti

  • Attitudes Regarding Transplantation During the Pandemic: Give Me My Kidney Now!

    T. Menser1, M. Hobeika2, A. Gaber2, H. Ibrahim2

  • Attitudes Towards Covid-19 Vaccination in an Inner-city Population of Kidney Transplant Patients (Ktx)

    P. Kerner, A. Imas, G. Udod, L. Gruffi, M. Goldberg, A. Saleh, K. Cruickshank, M. Markell

  • Augmented Responses of Donor Kidney Tubular Cells to TLR Signaling Correlate with Ameliorated Ischemia/reperfusion Injury and Long-term Allograft Protection

    X. Lai1, J. Wang1, L. Qiu2, S. Han1, K. Shen1, Z. Zhang1

  • Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B are Increased in Patients with Kidney Allograft Antibody-mediated Rejection

    S. Clotet-Freixas1, M. Kotlyar2, C. M. McEvoy1, C. Pastrello2, S. Rodríguez-Ramírez1, S. Farkona1, H. Cardinal3, M. Dieudé3, M. Hébert3, Y. Li1, O. Famure1, P. Chen1, S. Kim1, E. Chan4, I. Jurisica2, R. John1, A. Chruscinski1, A. Konvalinka1

  • Autoimmune Responses to DNA Topoisomerase I Exacerbate Renal Allograft Injury

    V. Gorbacheva, R. Fan, S. Miyairi, W. Baldwin, R. Fairchild, A. Valujskikh

  • Automated Electronic Donor Referrals Have Increased Transplantation

    J. Piano

  • Avoiding Tacrolimus Under- and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial

    M. I. Francke1, L. M. Andrews2, H. L. Le2, J. van de Wetering1, M. C. Clahsen-van Groningen3, T. van Gelder4, R. H. van Schaik5, B. van der Holt6, B. C. de Winter2, D. A. Hesselink1

  • Awareness of Teratogenic Potential of Mycophenolic Acid Products and Pregnancy Outcomes in Kidney Transplant Recipients

    S. Rao1, L. Coscia2, A. Yusuf2, S. Constantinescu3, M. J. Moritz4

Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences